Doctors reveal hospitalâs âThird World conditionsâ Doctors at a hospital in Sydneyâs booming south-west have described horrifying conditions as they beg the health minister for an upgrade.
Politics by Angira Bharadwaj and Anna Caldwell 5th May 2021 7:48 PM
Premium Content
Subscriber only Sixty senior doctors have penned a scathing letter to Health Minister Brad Hazzard calling out Third World conditions , inadequate facilities and grossly inadequate non-clinical space at Canterbury Hospital. In the letter, sent to Mr Hazzard on Christmas Eve, the doctors said their overwhelming concern remains the risk to patients as their number increases and ⦠capacity to serve them safely diminishes .
Academics partner with industry and policy makers on new research miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
A new trial in NSW has resulted in up to a 24 per cent reduction in the number of prescriptions issued for opioids to patients with acute back pain in.
Facebook has endangered public safety by blocking news on the platform in Australia during the covid-19 pandemic, according to Australia’s Treasurer Josh Frydenberg a high-ranking official in the country’s ruling Liberal Party.
Date Time
Could treatment with a statin preserve brain function after COVID-19 infection?
A new clinical trial led by a UNSW Medicine & Health professor receives more than $2.3m in funding.
An innovative study to assess whether a commonly used cholesterol lowering medication can prevent brain complications from COVID-19 has received more than $2.3 million from the Medical Research Future Fund (MRFF).
The study is a collaboration between The George Institute for Global Health, UNSW Sydney, Monash University’s School of Public Health, University of Sydney and Sydney Local Health District. It is one of six clinical trials to begin in 2021 that have received grants totalling $10 million through the MRFF Clinical Trials Activity Initiative.